Cargando…

Construction and Validation of a Protein Prognostic Model for Lung Squamous Cell Carcinoma

Lung squamous cell carcinoma (LUSCC), as the major type of lung cancer, has high morbidity and mortality rates. The prognostic markers for LUSCC are much fewer than lung adenocarcinoma. Besides, protein biomarkers have advantages of economy, accuracy and stability. The aim of this study was to const...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Xisheng, Liu, Xia, Weng, Chengyin, Wu, Yong, Li, Baoxiu, Mao, Haibo, Guan, Mingmei, Lu, Lin, Liu, Guolong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645351/ https://www.ncbi.nlm.nih.gov/pubmed/33162799 http://dx.doi.org/10.7150/ijms.47224

Ejemplares similares

Silencing UBE4B induces nasopharyngeal carcinoma apoptosis through the activation of caspase3 and p53
por: Weng, Chengyin, et al.
Publicado: (2019)

IL-17A promotes migration and tumor killing capability of B cells in esophageal squamous cell carcinoma
por: Lu, Lin, et al.
Publicado: (2016)

MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway
por: Lu, Lin, et al.
Publicado: (2019)

CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells
por: Lu, Lin, et al.
Publicado: (2020)

Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating NBL1 and activating the BMP2/Smad/ID1 pathway
por: Lu, Lin, et al.
Publicado: (2022)

Neuron specific enolase promotes tumor metastasis by activating the Wnt/β-catenin pathway in small cell lung cancer
por: Zha, Zhiqiang, et al.
Publicado: (2021)

Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma
por: Weng, Chengyin, et al.
Publicado: (2021)

Clinical significance of aberrant mammalian target of rapamycin expression in stage IIIB colon cancer
por: WEN, MEILING, et al.
Publicado: (2014)

Knockdown of neuron-specific enolase suppresses the proliferation and migration of NCI-H209 cells
por: Liu, Xia, et al.
Publicado: (2019)

CPNE8 Promotes Gastric Cancer Metastasis by Modulating Focal Adhesion Pathway and Tumor Microenvironment
por: Zhang, Peiling, et al.
Publicado: (2022)

Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma
por: Liu, Xia, et al.
Publicado: (2022)

Identification of a Somatic Mutation-Derived Long Non-Coding RNA Signatures of Genomic Instability in Renal Cell Carcinoma
por: Fang, Xisheng, et al.
Publicado: (2021)

Construction and validation of a prognostic nomogram for anal squamous cell carcinoma
por: Yang, Ningning, et al.
Publicado: (2021)

Predict Postoperative Anemia of Patients: Nomogram Construction and Validation
por: Dai, Yimin, et al.
Publicado: (2022)

Construction and validation of a seven-microRNA signature as a prognostic tool for lung squamous cell carcinoma
por: Gan, Zuhuan, et al.
Publicado: (2019)

Construction and validation of a tumor mutational burden and immune-related prognostic model for predicting the prognosis of patients with lung squamous cell carcinoma
por: Zhou, Yuting, et al.
Publicado: (2023)

Construction and Validation of an Immune-Related Gene Prognostic Index for Esophageal Squamous Cell Carcinoma
por: Ji, Qinghua, et al.
Publicado: (2021)

Construction and Validation of a UPR-Associated Gene Prognostic Model for Head and Neck Squamous Cell Carcinoma
por: Wang, Tao, et al.
Publicado: (2022)

Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics
por: Zhang, Jingfei, et al.
Publicado: (2022)

Construction and Validation of Prognosis Nomogram for Metastatic Lung Squamous Cell Carcinoma: A Population-Based Study
por: Liu, Yuting, et al.
Publicado: (2022)

Construction and validation of a prognostic nine-gene signature associated with radiosensitivity in head and neck squamous cell carcinoma
por: Lu, Congxian, et al.
Publicado: (2023)

Construction of a Two-Gene Immunogenomic-Related Prognostic Signature in Lung Squamous Cell Carcinoma
por: Zhang, Xiaoting, et al.
Publicado: (2022)

Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma
por: Ye, Fan, et al.
Publicado: (2022)

Identification and in vitro validation of diagnostic and prognostic biomarkers for lung squamous cell carcinoma
por: Zhao, Xiaopeng, et al.
Publicado: (2022)

Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma
por: Liu, Zeyu, et al.
Publicado: (2020)

Systematic construction and validation of an immune prognostic model for lung adenocarcinoma
por: Luo, Chenghan, et al.
Publicado: (2019)

Development and validation of an individualized immune prognostic model in stage I–III lung squamous cell carcinoma
por: Yang, Qi-Fan, et al.
Publicado: (2021)

Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis‐related genes
por: Diao, Xiayao, et al.
Publicado: (2021)

Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma
por: Chen, Danxia, et al.
Publicado: (2022)

Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patients
por: Liu, Xianyu, et al.
Publicado: (2022)

Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021)

Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma
por: Li, Wanzhen, et al.
Publicado: (2021)

Identification and validation of the angiogenic genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma
por: Zhu, Jinyu, et al.
Publicado: (2020)

Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma
por: Huang, Qiang, et al.
Publicado: (2022)

Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma
por: Bian, Jin, et al.
Publicado: (2021)

Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes
por: Jia, Erna, et al.
Publicado: (2022)

Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature
por: Lu, Lin, et al.
Publicado: (2022)

The construction and validation of ECM-related prognosis model in laryngeal squamous cell carcinoma
por: Jiang, Xue-fan, et al.
Publicado: (2023)

Ideal prognostic model in lung squamous cell carcinoma
por: Kinoshita, Tomonari
Publicado: (2020)

Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients
por: Zha, Zhiqiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cv3ra9b170a4vnpipj98k8tae6